Healthcare & Life Sciences
Am-Pharma
Netherlandsam-pharma.com
Am-Pharma is a Healthcare & Life Sciences startup based in the Netherlands, most recent round Series C+, 4 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2002
Founded
4
Investors
About Am-Pharma
Am-Pharma is a startup founded in 2002 based in the Netherlands. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
Am-Pharma develops ilofotase alfa, a recombinant human alkaline phosphatase enzyme replacement therapy targeting hypophosphatasia (HPP), a rare genetic metabolic disorder, to improve bone mineralization and address related symptoms in adult patients.
Explore Am-Pharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.